PROK Earnings Date: Nov 9, 2026 (Estimated) — ProKidney Corp.
NASDAQ
Updated
When is PROK's next earnings date?
ProKidney Corp. (PROK) is expected to report Q3 2026 earnings on Monday, November 9, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.13 on revenue of $124,600.
How did PROK do in its last earnings report?
In its most recent report on Aug 10, 2026 (Q2 2026), ProKidney Corp. posted EPS of -$0.15 versus the -$0.14 estimate, a miss of 7.1%. Revenue was $150,000 against a $186,250 estimate. The stock's 1-day post-earnings move was -4.7%.
How much does PROK stock move after earnings?
PROK beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 4.9% (up or down) in the day after earnings.
About ProKidney Corp.
ProKidney Corp. is a biotechnology firm currently in the clinical trial phase, specializing in the development of innovative cell-based treatments. Their flagship product is Renal Autologous Cell Therapy (RAC-T), a unique cellular admixture derived from a patient's own cells. RAC-T is undergoing significant clinical evaluation; it is concurrently in Phase III and Phase II trials for individuals with moderate to severe diabetic kidney disease. Furthermore, the company is conducting a Phase I clinical trial to assess RAC-T's potential for patients born with congenital anomalies affecting the kidneys and urinary tract. The company was established in 2015 and operates from its headquarters in Winston-Salem, North Carolina.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-10 | Q2 2026 | -0.14 | -0.15 | -7.14% | $150,000 | ❌ Miss | -4.73% | -17.16% | +9.47% |
| 2026-05-15 | Q1 2026 | -0.14 | -0.14 | +0.00% | $226,000 | ➖ Inline | -2.92% | +2.34% | -2.34% |
| 2026-03-18 | Q4 2025 | -0.15 | -0.14 | +6.67% | $225,000 | ✅ Beat | -6.25% | -12.02% | +4.81% |
| 2025-11-10 | Q3 2025 | -0.13 | -0.12 | +7.69% | $217,000 | ✅ Beat | -6.57% | -16.61% | -23.53% |
| 2025-08-12 | Q2 2025 | -0.14 | -0.13 | +7.14% | $221,000 | ✅ Beat | -0.67% | +12.64% | -4.21% |
| 2025-03-17 | Q4 2024 | -0.15 | -0.16 | -6.67% | $0 | ❌ Miss | +5.73% | -2.38% | -24.77% |
| 2024-08-09 | Q2 2024 | -0.17 | -0.16 | +5.88% | $0 | ✅ Beat | +4.31% | +14.35% | +14.35% |
| 2024-05-10 | Q1 2024 | -0.18 | -0.16 | +11.11% | $0 | ✅ Beat | +7.66% | +45.21% | +15.71% |
Showing last 8 quarters.